NASDAQ: WHWKWhitehawk Therapeutics Inc Stock Ownership - Who owns Whitehawk Therapeutics?
Insider buying vs selling
Have Whitehawk Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Bryan Ball | Chief Technical Operations Officer and SVP Manufacturing Operations | 2025-03-04 | 100,000 | $2.40 | $240.00kBuy |
| Baiteng Zhao | Director | 2025-03-04 | 1,250,000 | $2.40 | $3.00MBuy |
| Caley Castelein | Director | 2025-03-04 | 1,666,000 | $2.40 | $4.00MBuy |
| Anupam Dalal | Director | 2025-03-04 | 1,561,000 | $2.40 | $3.75MBuy |
| Scott M. Giacobello | CHIEF FINANCIAL OFFICER | 2025-03-03 | 2,806 | $2.35 | $6.59kSell |
| Bryan Ball | Chief Technical Operations Officer and SVP Manufacturing Operations | 2025-03-03 | 2,147 | $2.35 | $5.05kSell |
| David James Lennon | CHIEF EXECUTIVE OFFICER | 2025-03-03 | 5,690 | $2.35 | $13.37kSell |
| David James Lennon | CHIEF EXECUTIVE OFFICER | 2024-10-03 | 9,689 | $1.94 | $18.80kSell |
WHWK insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when WHWK insiders and whales buy or sell their stock.
WHWK Shareholders
What type of owners hold Whitehawk Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Muneer A. Satter | 11.93% | 5,621,835 | $11.19M | Insider |
| Orbimed Advisors LLC | 11.03% | 5,193,946 | $10.34M | Insider |
| Chau Quang Khuong | 11.03% | 5,193,946 | $10.34M | Insider |
| Qvt Financial LP | 9.80% | 4,615,709 | $9.19M | Institution |
| Orbimed Advisors LLC | 8.84% | 4,166,000 | $8.29M | Institution |
| Novartis Bioventures Ltd | 8.60% | 4,049,804 | $8.06M | Insider |
| Suvretta Capital Management LLC | 7.85% | 3,700,000 | $7.36M | Institution |
| Behzad Aghazadeh | 7.37% | 3,471,752 | $6.91M | Insider |
| Anupam Dalal | 7.24% | 3,411,532 | $6.79M | Insider |
| Acuta Capital Partners LLC | 7.24% | 3,410,402 | $6.79M | Institution |
WHWK vs Biotech Stocks
Whitehawk Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.